{"id":310272,"date":"2026-10-15T11:49:44","date_gmt":"2026-10-15T06:19:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=310272"},"modified":"2026-10-15T11:49:44","modified_gmt":"2026-10-15T06:19:44","slug":"diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/","title":{"rendered":"3 Diagnostic Lab, Surface Treatment and Rice Exporter Stocks With a Strong Future Roadmap: Suraksha Diagnostic, Grauer &#038; Weil (India) and LT Foods"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Suraksha Diagnostic Rs 318.30, P\/E 46.05. Grauer &amp; Weil Rs 81.06, P\/E 22.12. LT Foods Rs 418.05, P\/E 21.98. Closing prices of 14 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Diagnostic lab, surface treatment and rice exporter stocks with the clearest long-term roadmaps today include Suraksha Diagnostic in diagnostic and pathology testing through a network of labs and collection centres, Grauer &amp; Weil in surface treatment chemicals and related industrial products and LT Foods in basmati rice and packaged foods sold under brands such as Daawat. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 5.1% at Grauer &amp; Weil and 25.7% at LT Foods. P\/E stands at 46.05 for Suraksha Diagnostic (industry 62.79), 22.12 for Grauer &amp; Weil (industry 36.60) and 21.98 for LT Foods (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Diagnostic lab, surface treatment and rice exporter stocks give investors exposure to health testing, industrial chemicals and food staples sold at home and abroad. Volumes, pricing and input costs decide how much of that demand turns into profit.<\/p>\n<p>Readers comparing diagnostic lab, surface treatment and rice exporter stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.<\/p>\n<p>This list covers three diagnostic lab, surface treatment and rice exporter stocks: Suraksha Diagnostic for diagnostic and pathology testing through a network of labs and collection centres, Grauer &amp; Weil (India) for surface treatment chemicals and related industrial products and LT Foods for basmati rice and packaged foods sold under brands such as Daawat. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#What_Are_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks\" title=\"What Are Diagnostic Lab, Surface Treatment and Rice Exporter Stocks?\">What Are Diagnostic Lab, Surface Treatment and Rice Exporter Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks_at_a_Glance\" title=\"Diagnostic Lab, Surface Treatment and Rice Exporter Stocks at a Glance\">Diagnostic Lab, Surface Treatment and Rice Exporter Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Why_Do_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Diagnostic Lab, Surface Treatment and Rice Exporter Stocks Have a Strong Roadmap in India?\">Why Do Diagnostic Lab, Surface Treatment and Rice Exporter Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Suraksha_Diagnostic_Diagnostic_Labs_Drive_the_Pipeline\" title=\"Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline\">Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Grauer_Weil_India_Surface_Treatment_Chemicals_Drive_the_Pipeline\" title=\"Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline\">Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#LT_Foods_Basmati_and_Packaged_Foods_Anchor_the_Roadmap\" title=\"LT Foods: Basmati and Packaged Foods Anchor the Roadmap\">LT Foods: Basmati and Packaged Foods Anchor the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Best_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks_in_India_Suraksha_Diagnostic_vs_Grauer_Weil_vs_LT_Foods_on_Key_Financials\" title=\"Best Diagnostic Lab, Surface Treatment and Rice Exporter Stocks in India: Suraksha Diagnostic vs Grauer &amp; Weil vs LT Foods on Key Financials\">Best Diagnostic Lab, Surface Treatment and Rice Exporter Stocks in India: Suraksha Diagnostic vs Grauer &amp; Weil vs LT Foods on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#How_to_Evaluate_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Diagnostic Lab, Surface Treatment and Rice Exporter Stocks to Buy Before You Invest\">How to Evaluate Diagnostic Lab, Surface Treatment and Rice Exporter Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Risks_to_Consider_Before_Investing_in_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks\" title=\"Risks to Consider Before Investing in Diagnostic Lab, Surface Treatment and Rice Exporter Stocks\">Risks to Consider Before Investing in Diagnostic Lab, Surface Treatment and Rice Exporter Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#FAQs_on_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks\" title=\"FAQs on Diagnostic Lab, Surface Treatment and Rice Exporter Stocks\">FAQs on Diagnostic Lab, Surface Treatment and Rice Exporter Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Which_are_the_best_diagnostic_lab_surface_treatment_and_rice_exporter_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best diagnostic lab, surface treatment and rice exporter stocks in India with a strong roadmap?\">Which are the best diagnostic lab, surface treatment and rice exporter stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Is_Suraksha_Diagnostic_a_good_stock_to_buy_now\" title=\"Is Suraksha Diagnostic a good stock to buy now?\">Is Suraksha Diagnostic a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#What_is_the_PE_ratio_of_Suraksha_Diagnostic_Grauer_Weil_and_LT_Foods\" title=\"What is the P\/E ratio of Suraksha Diagnostic, Grauer &amp; Weil and LT Foods?\">What is the P\/E ratio of Suraksha Diagnostic, Grauer &amp; Weil and LT Foods?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Which_of_these_diagnostic_lab_surface_treatment_and_rice_exporter_stocks_has_the_highest_return_on_equity\" title=\"Which of these diagnostic lab, surface treatment and rice exporter stocks has the highest return on equity?\">Which of these diagnostic lab, surface treatment and rice exporter stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#What_are_the_risks_of_investing_in_diagnostic_lab_surface_treatment_and_rice_exporter_stocks\" title=\"What are the risks of investing in diagnostic lab, surface treatment and rice exporter stocks?\">What are the risks of investing in diagnostic lab, surface treatment and rice exporter stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#How_did_Suraksha_Diagnostic_Grauer_Weil_and_LT_Foods_perform_in_Q1_FY27\" title=\"How did Suraksha Diagnostic, Grauer &amp; Weil and LT Foods perform in Q1 FY27?\">How did Suraksha Diagnostic, Grauer &amp; Weil and LT Foods perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#Do_diagnostic_lab_surface_treatment_and_rice_exporter_stocks_pay_dividends\" title=\"Do diagnostic lab, surface treatment and rice exporter stocks pay dividends?\">Do diagnostic lab, surface treatment and rice exporter stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/diagnostic-lab-surface-treatment-and-rice-exporter-stocks-roadmap-compass-list\/#How_can_I_invest_in_diagnostic_lab_surface_treatment_and_rice_exporter_stocks_in_India\" title=\"How can I invest in diagnostic lab, surface treatment and rice exporter stocks in India?\">How can I invest in diagnostic lab, surface treatment and rice exporter stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks\"><\/span><strong>What Are Diagnostic Lab, Surface Treatment and Rice Exporter Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnostic lab, surface treatment and rice exporter stocks are shares of companies that run diagnostics, make chemicals or sell packaged food. Results depend on volumes, pricing and input costs, so margins and cash flow separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks_at_a_Glance\"><\/span><strong>Diagnostic Lab, Surface Treatment and Rice Exporter Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three diagnostic lab, surface treatment and rice exporter stocks as of the 14 Oct 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/suraksha\/suraksha-diagnostic-ltd-share-price-today\">Suraksha Diagnostic<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">318.30<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,614<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">46.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.79<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.15%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.53<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/grauweil\/grauer-weil-india-ltd-share-price-today\">Grauer &amp; Weil (India)<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">81.06<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,540<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.12<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.60<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.16%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/ltfoods\/lt-foods-ltd-share-price-today\">LT Foods<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">418.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,072<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.98<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.85<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.83%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.36<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare and chemicals stocks, all three trade at a discount to their industry P\/E multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Diagnostic Lab, Surface Treatment and Rice Exporter Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnostic lab, surface treatment and rice exporter stocks have a strong roadmap in India because rising health checks, industrial output and global appetite for basmati keep adding volumes for these firms. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Preventive health:<\/strong> More people test early and often.<\/li>\n<li><strong>Industrial output:<\/strong> Factories use surface treatment chemicals regularly.<\/li>\n<li><strong>Rice exports:<\/strong> Global buyers prefer basmati varieties.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Suraksha_Diagnostic_Diagnostic_Labs_Drive_the_Pipeline\"><\/span><strong>Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Suraksha Diagnostic&#8217;s roadmap rests on diagnostic and pathology testing through a network of labs and collection centres, with rising health screening supporting test volumes.<\/p>\n<p>Revenue grew from Rs 225.50 crore in FY22 to Rs 313.58 crore in FY26, a 39.1% rise, and FY26 revenue was 22.5% higher than FY25. FY26 net profit rose 1.4% to Rs 31.40 crore. Over four years, net profit rose from Rs 23.75 crore in FY22 to Rs 31.40 crore. In Q1 FY27, revenue grew 20.7% to Rs 88.74 crore, and net profit rose 40.0% to Rs 12.85 crore. Operating margin was 32.01% in FY26 and 35.97% in Q1 FY27 against 33.97% a year earlier.<\/p>\n<p>Debt to equity is 0.53 and return on equity is 13.15%. FY26 operating cash flow was Rs 81.83 crore against capital expenditure of Rs 67.34 crore. Suraksha Diagnostic paid a dividend of Rs 0.05 per share for FY26, a yield of 0.02%. At a P\/E of 46.05 against an industry P\/E of 62.79, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Q1 FY27 operating margin was 35.97% against 32.01% for FY26, so margin stability is the figure to follow as volumes grow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Grauer_Weil_India_Surface_Treatment_Chemicals_Drive_the_Pipeline\"><\/span><strong>Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Grauer &amp; Weil&#8217;s roadmap rests on surface treatment chemicals and related industrial products, with several business lines supporting earnings.<\/p>\n<p>Revenue grew from Rs 782.11 crore in FY22 to Rs 1,239.78 crore in FY26, a 58.5% rise, and FY26 revenue was 5.1% higher than FY25. FY26 net profit rose 4.3% to Rs 164.03 crore. Over four years, net profit rose from Rs 78.77 crore in FY22 to Rs 164.03 crore. In Q1 FY27, revenue grew 17.0% to Rs 311.11 crore. Operating margin was 18.87% in FY26.<\/p>\n<p>Debt to equity is 0.01 and return on equity is 15.16%. FY26 operating cash flow was Rs 151.86 crore against capital expenditure of Rs 53.65 crore. Grauer &amp; Weil paid a dividend of Rs 1 per share for FY26, a yield of 1.28%. At a P\/E of 22.12 against an industry P\/E of 36.60, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 22.12 against an industry P\/E of 36.60 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"LT_Foods_Basmati_and_Packaged_Foods_Anchor_the_Roadmap\"><\/span><strong>LT Foods: Basmati and Packaged Foods Anchor the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>LT Foods&#8217; roadmap rests on basmati rice and packaged foods sold under brands such as Daawat, with exports and branded sales supporting revenue.<\/p>\n<p>Revenue grew from Rs 5,450.58 crore in FY22 to Rs 11,023.06 crore in FY26, a 102.2% rise, and FY26 revenue was 25.7% higher than FY25. FY26 net profit rose 2.2% to Rs 625.38 crore. Over four years, net profit rose from Rs 309.20 crore in FY22 to Rs 625.38 crore. In Q1 FY27, revenue grew 26.4% to Rs 3,161.29 crore, and net profit rose 8.9% to Rs 183.45 crore. Operating margin was 11.35% in FY26.<\/p>\n<p>Debt to equity is 0.36 and return on equity is 13.83%. FY26 operating cash flow was Rs 910.50 crore against capital expenditure of Rs 359.62 crore. LT Foods paid a dividend of Rs 3 per share for FY26, a yield of 0.74%. At a P\/E of 21.98 against an industry P\/E of 34.85, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 21.98 against an industry P\/E of 34.85 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks_in_India_Suraksha_Diagnostic_vs_Grauer_Weil_vs_LT_Foods_on_Key_Financials\"><\/span><strong>Best Diagnostic Lab, Surface Treatment and Rice Exporter Stocks in India: Suraksha Diagnostic vs Grauer &amp; Weil vs LT Foods on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best diagnostic lab, surface treatment and rice exporter stocks in India, Suraksha Diagnostic leads on FY26 operating margin; Grauer &amp; Weil leads on FY26 net profit growth and return on equity; LT Foods leads on FY26 revenue growth and Q1 FY27 revenue growth. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Suraksha Diagnostic<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Grauer &amp; Weil<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">LT Foods<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">313.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,239.78<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11,023.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.40<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">164.03<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">625.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.01%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.87%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.15%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.16%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">46.05<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.12<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.98<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.53<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.02%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.28%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating cash flow (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">81.83<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">151.86<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">910.50<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare, chemicals and food earnings follow volumes, pricing and input costs, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Diagnostic Lab, Surface Treatment and Rice Exporter Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen diagnostic lab, surface treatment and rice exporter stocks and shortlist diagnostic lab, surface treatment and rice exporter stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by company here.<\/li>\n<li>Check operating margin, debt and cash flow together.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these diagnostic lab, surface treatment and rice exporter stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks\"><\/span><strong>Risks to Consider Before Investing in Diagnostic Lab, Surface Treatment and Rice Exporter Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Input costs:<\/strong> Changes in raw material prices can affect margins.<\/li>\n<li><strong>Seasonal demand:<\/strong> Weather and crop cycles can shift sales between quarters.<\/li>\n<li><strong>Quarterly trends:<\/strong> A single weak quarter can change near-term earnings, so track results every quarter.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Suraksha Diagnostic, Grauer &amp; Weil and LT Foods live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three healthcare and chemicals stocks cover diagnostics, surface treatment chemicals and basmati rice. Suraksha Diagnostic leads on FY26 operating margin; Grauer &amp; Weil leads on FY26 net profit growth and return on equity; LT Foods leads on FY26 revenue growth and Q1 FY27 revenue growth.<\/p>\n<p>Across diagnostic lab, surface treatment and rice exporter stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the diagnostic lab, surface treatment and rice exporter stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Diagnostic_Lab_Surface_Treatment_and_Rice_Exporter_Stocks\"><\/span><strong>FAQs on Diagnostic Lab, Surface Treatment and Rice Exporter Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_diagnostic_lab_surface_treatment_and_rice_exporter_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best diagnostic lab, surface treatment and rice exporter stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic, Grauer &amp; Weil (India) and LT Foods stand out for their roadmaps in diagnostics, surface treatment chemicals and basmati rice. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 5.1% at Grauer &amp; Weil and 25.7% at LT Foods, and return on equity ranges from 13.15% to 15.16%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Suraksha_Diagnostic_a_good_stock_to_buy_now\"><\/span><strong>Is Suraksha Diagnostic a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P\/E of 46.05 against an industry P\/E of 62.79. Valuation, input costs and seasonal demand move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Suraksha_Diagnostic_Grauer_Weil_and_LT_Foods\"><\/span><strong>What is the P\/E ratio of Suraksha Diagnostic, Grauer &amp; Weil and LT Foods?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 22.12 for Grauer &amp; Weil (industry 36.60) and 21.98 for LT Foods (industry 34.85). All of them trade below the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_diagnostic_lab_surface_treatment_and_rice_exporter_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these diagnostic lab, surface treatment and rice exporter stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Grauer &amp; Weil (India) has the highest return on equity at 15.16%, followed by LT Foods at 13.83% and Suraksha Diagnostic at 13.15%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_diagnostic_lab_surface_treatment_and_rice_exporter_stocks\"><\/span><strong>What are the risks of investing in diagnostic lab, surface treatment and rice exporter stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are input costs, seasonal demand and quarterly trends. Changes in raw material prices can affect margins.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Suraksha_Diagnostic_Grauer_Weil_and_LT_Foods_perform_in_Q1_FY27\"><\/span><strong>How did Suraksha Diagnostic, Grauer &amp; Weil and LT Foods perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. Grauer &amp; Weil (India) reported revenue of Rs 311.11 crore, up 17.0% year on year. LT Foods reported revenue of Rs 3,161.29 crore, up 26.4% year on year, and net profit rose 8.9% to Rs 183.45 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_diagnostic_lab_surface_treatment_and_rice_exporter_stocks_pay_dividends\"><\/span><strong>Do diagnostic lab, surface treatment and rice exporter stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, all three companies pay dividends. The dividend yield is 0.02% for Suraksha Diagnostic, 1.28% for Grauer &amp; Weil and 0.74% for LT Foods, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_diagnostic_lab_surface_treatment_and_rice_exporter_stocks_in_India\"><\/span><strong>How can I invest in diagnostic lab, surface treatment and rice exporter stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy diagnostic lab, surface treatment and rice exporter stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best diagnostic lab, surface treatment and rice exporter stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic, Grauer & Weil (India) and LT Foods stand out for their roadmaps in diagnostics, surface treatment chemicals and basmati rice. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 5.1% at Grauer & Weil and 25.7% at LT Foods, and return on equity ranges from 13.15% to 15.16%.\"}},{\"@type\":\"Question\",\"name\":\"Is Suraksha Diagnostic a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P\/E of 46.05 against an industry P\/E of 62.79. Valuation, input costs and seasonal demand move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Suraksha Diagnostic, Grauer & Weil and LT Foods?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 22.12 for Grauer & Weil (industry 36.60) and 21.98 for LT Foods (industry 34.85). All of them trade below the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these diagnostic lab, surface treatment and rice exporter stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Grauer & Weil (India) has the highest return on equity at 15.16%, followed by LT Foods at 13.83% and Suraksha Diagnostic at 13.15%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in diagnostic lab, surface treatment and rice exporter stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are input costs, seasonal demand and quarterly trends. Changes in raw material prices can affect margins.\"}},{\"@type\":\"Question\",\"name\":\"How did Suraksha Diagnostic, Grauer & Weil and LT Foods perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. Grauer & Weil (India) reported revenue of Rs 311.11 crore, up 17.0% year on year. LT Foods reported revenue of Rs 3,161.29 crore, up 26.4% year on year, and net profit rose 8.9% to Rs 183.45 crore.\"}},{\"@type\":\"Question\",\"name\":\"Do diagnostic lab, surface treatment and rice exporter stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, all three companies pay dividends. The dividend yield is 0.02% for Suraksha Diagnostic, 1.28% for Grauer & Weil and 0.74% for LT Foods, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in diagnostic lab, surface treatment and rice exporter stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy diagnostic lab, surface treatment and rice exporter stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Suraksha Diagnostic, Grauer &#038; Weil (India) and LT Foods compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":34,"featured_media":310270,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[12410,11165,11131,12411,12412],"class_list":["post-310272","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-diagnostic-lab","tag-lt-foods","tag-suraksha-diagnostic","tag-surface-treatment-and-rice-exporter-stocks","tag-surface-treatment-and-rice-exporter-stocks-to-buy"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["310270"],"rank_math_title":["Diagnostic Lab, Surface Treatment and Rice Exporter Stocks"],"rank_math_description":["Diagnostic lab, surface treatment and rice exporter stocks with a strong roadmap compared on growth, margins, valuation and risks."],"rank_math_focus_keyword":["diagnostic lab, surface treatment and rice exporter stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-diagnostic-lab-surface-treatment-and-rice-exporter-stocks-with-a-strong-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=310272"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310272\/revisions"}],"predecessor-version":[{"id":310273,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310272\/revisions\/310273"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/310270"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=310272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=310272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=310272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}